BKD
Price
$9.10Alerts
Change
-$0.12 (-1.30%)
Updated
Nov 12, 03:12 PM (EDT)
Capitalization
2.15B
103 days until earnings call
Intraday BUY SELL Signals
MD
Price
$31.55Alerts
Change
+$0.10 (+0.32%)
Updated
Nov 12, 03:25 PM (EDT)
Capitalization
2.54B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BKD vs MD

BKD vs MD Comparison Chart in %
View a ticker or compare two or three
VS
BKD vs. MD commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BKD is a Hold and MD is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BKD with price predictions
Nov 11, 2026

BKD in upward trend: price may jump up because it broke its lower Bollinger Band on November 06, 2026

BKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 42 cases where BKD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BKD's RSI Oscillator exited the oversold zone, 25 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +4.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where BKD advanced for three days, in 228 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BKD as a result. In 71 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for BKD turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 39 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

BKD moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BKD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for BKD entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-74.262) is normal, around the industry mean (204.532). P/E Ratio (-15.271) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (2.498). Dividend Yield (0.111) settles around the average of (0.154) among similar stocks. P/S Ratio (0.916) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. BKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BKD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for MD with price predictions
Nov 11, 2026

MD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MD turned positive on October 08, 2026. Looking at past instances where MD's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MD as a result. In 67 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

MD moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MD crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.

Following a +1.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where MD advanced for three days, in 195 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

The Aroon Indicator entered an Uptrend today. In 134 of 198 cases where MD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.

Bearish Trend Analysis

The 10-day RSI Indicator for MD moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 19 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 59 cases where MD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

MD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. MD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.886) is normal, around the industry mean (204.532). P/E Ratio (14.690) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.119) is also within normal values, averaging (2.688).

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
BKD vs MD: Fundamental Ratings
BKD
MD
OUTLOOK RATING
1..100
1128
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
7683
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
7337
P/E GROWTH RATING
1..100
1218
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BKD's Valuation (6) in the Hospital Or Nursing Management industry is somewhat better than the same rating for MD (60) in the Medical Or Nursing Services industry. This means that BKD’s stock grew somewhat faster than MD’s over the last 12 months.

BKD's Profit vs Risk Rating (76) in the Hospital Or Nursing Management industry is in the same range as MD (83) in the Medical Or Nursing Services industry. This means that BKD’s stock grew similarly to MD’s over the last 12 months.

MD's SMR Rating (46) in the Medical Or Nursing Services industry is somewhat better than the same rating for BKD (100) in the Hospital Or Nursing Management industry. This means that MD’s stock grew somewhat faster than BKD’s over the last 12 months.

MD's Price Growth Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for BKD (73) in the Hospital Or Nursing Management industry. This means that MD’s stock grew somewhat faster than BKD’s over the last 12 months.

BKD's P/E Growth Rating (12) in the Hospital Or Nursing Management industry is in the same range as MD (18) in the Medical Or Nursing Services industry. This means that BKD’s stock grew similarly to MD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BKDMD
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 4 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
65%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 7 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BKD: $9.22 vs. MD: $31.45)
Brand notoriety: BKD and MD are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: BKD: 244% vs. MD: 124%
Market capitalization -- BKD: $2.15B vs. MD: $2.54B
BKD [@Hospital/Nursing Management] is valued at $2.15B. MD’s [@Hospital/Nursing Management] market capitalization is $2.54B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BKD’s FA Score shows that 2 FA rating(s) are green while MD’s FA Score has 1 green FA rating(s).

  • BKD’s FA Score: 2 green, 3 red.
  • MD’s FA Score: 1 green, 4 red.
According to our system of comparison, MD is a better buy in the long-term than BKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BKD’s TA Score shows that 4 TA indicator(s) are bullish while MD’s TA Score has 6 bullish TA indicator(s).

  • BKD’s TA Score: 4 bullish, 5 bearish.
  • MD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MD is a better buy in the short-term than BKD.

Price Growth

BKD (@Hospital/Nursing Management) experienced а -17.60% price change this week, while MD (@Hospital/Nursing Management) price change was -4.12% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -4.18%. For the same industry, the average monthly price growth was +1.01%, and the average quarterly price growth was +10.84%.

Reported Earning Dates

BKD is expected to report earnings on Feb 23, 2027.

MD is expected to report earnings on Feb 18, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-4.18% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

BKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BKD has been loosely correlated with SNDA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BKD jumps, then SNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BKD
1D Price
Change %
BKD100%
-1.71%
SNDA - BKD
47%
Loosely correlated
+0.65%
ENSG - BKD
36%
Loosely correlated
+0.59%
MD - BKD
30%
Poorly correlated
-0.54%
THC - BKD
28%
Poorly correlated
+0.93%
HCA - BKD
25%
Poorly correlated
+0.32%
More

MD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MD has been loosely correlated with UHS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MD jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MD
1D Price
Change %
MD100%
-0.54%
UHS - MD
37%
Loosely correlated
+0.70%
HCA - MD
35%
Loosely correlated
+0.32%
CON - MD
34%
Loosely correlated
+1.83%
NHC - MD
34%
Loosely correlated
+0.87%
EHC - MD
32%
Poorly correlated
-0.19%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ADIU11.940.84
+7.59%
Leverage Shares 2X Long ADI Daily ETF (ADIU)
AIBU57.472.63
+4.80%
Direxion Daily AI and Big Data Bull 2X ETF (AIBU)
BUFZ28.650.22
+0.77%
FT Vest Laddered Moderate Buffer ETF (BUFZ)
DVOL37.250.18
+0.49%
First Trust Dorsey Wright Momentum & Low Volatility ETF (DVOL)
FDM90.990.42
+0.46%
First Trust Dow Jones Select MicroCap Index Fund (FDM)